Table 4. Evaluated screening strategies for breast cancer in women with a BRCA1/2/u mutation.
| Age (years) | Dutch strategy | UK strategy | US strategy |
|---|---|---|---|
| 25–30 |
MRI every year |
No screening |
MRI and mammography every year |
| 30–50 |
MRI and mammography every year |
MRI and mammography every year |
MRI and mammography every year |
| 50–60 |
MRI and mammography every year |
Mammography every 3 years in NBSP |
MRI and mammography every year |
| 60–70 |
Mammography every 2 years in NBSP |
Mammography every 3 years in NBSP |
MRI and mammography every year |
| 70–75 |
Mammography every 2 years in NBSP |
No screening |
MRI and mammography every year |
| Age over 75 when being in good health | No screening | No screening | MRI and mammography every year |
Abbreviation: NBSP=National Breast Cancer Screening Program.